These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 20814782

  • 1. Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.
    Zayara AE, McIver G, Valdivia PN, Lominac KD, McCreary AC, Szumlinski KK.
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):321-35. PubMed ID: 20814782
    [Abstract] [Full Text] [Related]

  • 2. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL, Rizos Z, Diwan M, Nobrega JN, Fletcher PJ.
    Behav Brain Res; 2013 Mar 01; 240():171-81. PubMed ID: 23201361
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    McMahon LR, Filip M, Cunningham KA.
    J Neurosci; 2001 Oct 01; 21(19):7781-7. PubMed ID: 11567068
    [Abstract] [Full Text] [Related]

  • 4. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA, Olabisi OA, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May 01; 28(3):547-57. PubMed ID: 15093963
    [Abstract] [Full Text] [Related]

  • 5. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S, De Deurwaerdère P, Porras G, Spampinato U.
    Neuropsychopharmacology; 2004 Feb 01; 29(2):319-26. PubMed ID: 14560323
    [Abstract] [Full Text] [Related]

  • 6. Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task.
    Robinson ES, Dalley JW, Theobald DE, Glennon JC, Pezze MA, Murphy ER, Robbins TW.
    Neuropsychopharmacology; 2008 Sep 01; 33(10):2398-406. PubMed ID: 18046307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
    Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH.
    J Pharmacol Exp Ther; 2010 Dec 01; 335(3):728-34. PubMed ID: 20858706
    [Abstract] [Full Text] [Related]

  • 9. Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens.
    Leggio GM, Cathala A, Moison D, Cunningham KA, Piazza PV, Spampinato U.
    Neuropharmacology; 2009 Feb 01; 56(2):507-13. PubMed ID: 18977370
    [Abstract] [Full Text] [Related]

  • 10. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
    De Deurwaerdère P, Navailles S, Berg KA, Clarke WP, Spampinato U.
    J Neurosci; 2004 Mar 31; 24(13):3235-41. PubMed ID: 15056702
    [Abstract] [Full Text] [Related]

  • 11. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.
    Psychopharmacology (Berl); 2005 Dec 31; 183(2):144-53. PubMed ID: 16220333
    [Abstract] [Full Text] [Related]

  • 12. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Shamma H, Smith B, Chalmers D, Behan D.
    J Pharmacol Exp Ther; 2008 May 31; 325(2):577-87. PubMed ID: 18252809
    [Abstract] [Full Text] [Related]

  • 13. 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.
    Pockros LA, Pentkowski NS, Conway SM, Ullman TE, Zwick KR, Neisewander JL.
    Synapse; 2012 Dec 31; 66(12):989-1001. PubMed ID: 22886755
    [Abstract] [Full Text] [Related]

  • 14. The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys.
    Manvich DF, Kimmel HL, Cooper DA, Howell LL.
    J Pharmacol Exp Ther; 2012 Sep 31; 342(3):761-9. PubMed ID: 22685342
    [Abstract] [Full Text] [Related]

  • 15. Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats.
    Pockros LA, Pentkowski NS, Swinford SE, Neisewander JL.
    Psychopharmacology (Berl); 2011 Feb 31; 213(2-3):307-20. PubMed ID: 21079923
    [Abstract] [Full Text] [Related]

  • 16. Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine.
    Katsidoni V, Apazoglou K, Panagis G.
    Psychopharmacology (Berl); 2011 Feb 31; 213(2-3):337-54. PubMed ID: 20577718
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M, McCreary AC, Wydra K, Filip M.
    Synapse; 2010 Jul 31; 64(7):511-9. PubMed ID: 20196140
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
    Fletcher PJ, Grottick AJ, Higgins GA.
    Neuropsychopharmacology; 2002 Oct 31; 27(4):576-86. PubMed ID: 12377394
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 31; 28(1):157-71. PubMed ID: 14687870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.